Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC.TMCI · Entity 5943 | SVP, Sales | April 22, 2021 | April 26, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TREACE MEDICAL CONCEPTS, INC.
Report date April 22, 2021 · Filed April 26, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.00 · Expires 2031-04-22 | Direct | 13,375 |
Reported balance
After 2021-04-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-04-22 · Grant · Acquired 13,375 · Balance 13,375 F1: The stock option will vest in equal annual installments over 4 years, commencing on April 22, 2022, with the last installment on April 22, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option will vest in equal annual installments over 4 years, commencing on April 22, 2022, with the last installment on April 22, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 22, 2021 Filed Apr 26, 2021 20:55 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantStock Option (Right to Buy) · Derivative | 13,375 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000899243-21-017021 · doc4.xml · derivative · entry 1 Rajhansa Dipak · CIK 0001856376 · SVP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,375 Underlying: Common Stock · 13,375 shares Expires 2031-04-22 F1 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on April 22, 2022, with the last installment on April 22, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.